饮水增加指导对慢性肾病患者肾功能下降的影响:CKD WIT随机临床试验
该随机临床试验在加拿大安大略省9个中心纳入631例3期慢性肾病患者,比较饮水增加指导与维持习惯饮水的效果。
要点
- 增加饮水指导未显著延缓3期CKD患者1年eGFR下降。
- hydration组24小时尿量平均增加0.6 L/d(95%CI 0.5-0.7)。
- 研究可能把握度不足,不能排除临床重要差异。
核心结论
- 在3期慢性肾病患者中,指导增加饮水较维持习惯饮水未显著延缓1年肾功能下降。
研究设计与样本
- CKD WIT为随机临床试验,2013至2017年在加拿大安大略省9个中心开展,纳入631例3期CKD且24小时尿量<3.0 L的患者。
主要发现
- hydration组24小时尿量较control组平均多增加0.6 L/d(95%CI 0.5至0.7,P<.001)。
关键数值与推荐
- 入组标准:eGFR 30-60 mL/min/1.73 m2且伴微量或大量白蛋白尿,24小时尿量<3.0 L。
- 主要结局为基线至12个月eGFR变化;hydration组n=316,control组n=315。
临床怎么用
- 对3期CKD患者,常规指导增加饮水至>3.0 L/d未显示延缓eGFR下降的获益。
- 临床决策时应结合患者容量状态与合并症,不应仅以增加尿量为目标。
局限性
- 研究可能把握度不足,无法检出临床重要差异。
- 12个月随访期间12例死亡(hydration组5例,control组7例),590例有1年随访测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In observational studies, increased water intake is associated with better kidney function. OBJECTIVE: To determine the effect of coaching to increase water intake on kidney function in adults with chronic kidney disease. DESIGN, SETTING, AND PARTICIPANTS: The CKD WIT (Chronic Kidney Disease Water Intake Trial) randomized clinical trial was conducted in 9 centers in Ontario, Canada, from 2013 until 2017 (last day of follow-up, May 25, 2017). Patients had stage 3 chronic kidney disease (estimated glomerular filtration rate [eGFR] 30-60 mL/min/1.73 m2 and microalbuminuria or macroalbuminuria) and a 24-hour urine volume of less than 3.0 L. INTERVENTIONS: Patients in the hydration group (n = 316) were coached to drink more water, and those in the control group (n = 315) were coached to maintain usual intake. MAIN OUTCOMES AND MEASURES: The primary outcome was change in kidney function (eGFR from baseline to 12 months). Secondary outcomes included 1-year change in plasma copeptin concentration, creatinine clearance, 24-hour urine albumin, and patient-reported overall quality of health (0 [worst possible] to 10 [best possible]). RESULTS: Of 631 randomized patients (mean age, 65.0 years; men, 63.4%; mean eGFR, 43 mL/min/1.73 m2; median urine albumin, 123 mg/d), 12 died (hydration group [n = 5]; control group [n = 7]). Among 590 survivors with 1-year follow-up measurements (95% of 619), the mean change in 24-hour urine volume was 0.6 L per day higher in the hydration group (95% CI, 0.5 to 0.7; P < .001). The mean change in eGFR was -2.2 mL/min/1.73 m2 in the hydration group and -1.9 mL/min/1.73 m2 in the control group (adjusted between-group difference, -0.3 mL/min/1.73 m2 [95% CI, -1.8 to 1.2; P = .74]). The mean between-group differences (hydration vs control) in secondary outcomes were as follows: plasma copeptin, -2.2 pmol/L (95% CI, -3.9 to -0.5; P = .01); creatinine clearance, 3.6 mL/min/1.73 m2 (95% CI, 0.8 to 6.4; P = .01); urine albumin, 7 mg per day (95% CI, -4 to 51; P = .11); and quality of health, 0.2 points (95% CI, -0.3 to 0.3; P = .22). CONCLUSIONS AND RELEVANCE: Among adults with chronic kidney disease, coaching to increase water intake compared with coaching to maintain the same water intake did not significantly slow the decline in kidney function after 1 year. However, the study may have been underpowered to detect a clinically important difference. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01766687.
引用
- Clark WF, Sontrop JM, Huang SH, et al. Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial. JAMA. 2018. PMID: 29801012. doi:10.1001/jama.2018.4930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。